MedTrace Logo

L-Arginine Role for Stone Lower Ureter : A Randomized Control Study

NCT06753526 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 153

Last updated 2024-12-31

No results posted yet for this study

Summary

To evaluate the effects of L-Arginine 1000mg once daily as a medical expulsive therapy (MET) for lower ureter stones.

Conditions

  • Stone Lower Ureter

Interventions

DRUG

NSAID

For 1st group of patients

DRUG

L-Arginine, 500 Mg Oral Capsule

group 2by twice dose

DRUG

Tamsulosin 0.4 mg QD

group 3 by once per day

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2024-04-30
Completion
2024-06-30
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06753526 on ClinicalTrials.gov